Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

S-8 - Securities to be offered to employees in employee benefit plans

Form Type: S-8

Filing Date: 2016-03-18

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2016-03-11

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2016-02-26

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2016-02-16

View Filing

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2016-02-12

View Filing

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2016-02-12

View Filing

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2016-02-12

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2016-02-12

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2016-02-11

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2016-02-11

View Filing